C-reactive protein levels in acute respiratory exacerbations of cystic fibrosis

Gayan Kathriachchige, Christopher Daley, Michael Pallin, Kevan Polkinghorne, Paul T. King

Research output: Contribution to journalArticleResearchpeer-review

Abstract

C-reactive protein (CRP) levels increase in response to bacterial infection and have been used to guide the use of antibiotics. We assessed CRP levels in a cohort of patients with cystic fibrosis (CF) admitted to hospital with an exacerbation of their lung disease, requiring treatment with broad-spectrum antibiotics. In this group, most subjects had CRP levels of less than 20 mg/L, including patients who had pneumonia. The clinical utility of the CRP in guiding antibiotic use in exacerbations of CF is limited.

Original languageEnglish
Pages (from-to)1392-1395
Number of pages4
JournalInternal Medicine Journal
Volume48
Issue number11
DOIs
Publication statusPublished - 1 Nov 2018

Keywords

  • antibiotic
  • C-reactive protein
  • exacerbation
  • pneumonia

Cite this

Kathriachchige, Gayan ; Daley, Christopher ; Pallin, Michael ; Polkinghorne, Kevan ; King, Paul T. / C-reactive protein levels in acute respiratory exacerbations of cystic fibrosis. In: Internal Medicine Journal. 2018 ; Vol. 48, No. 11. pp. 1392-1395.
@article{d7ab49d6b95a4de08b6cc572870b69de,
title = "C-reactive protein levels in acute respiratory exacerbations of cystic fibrosis",
abstract = "C-reactive protein (CRP) levels increase in response to bacterial infection and have been used to guide the use of antibiotics. We assessed CRP levels in a cohort of patients with cystic fibrosis (CF) admitted to hospital with an exacerbation of their lung disease, requiring treatment with broad-spectrum antibiotics. In this group, most subjects had CRP levels of less than 20 mg/L, including patients who had pneumonia. The clinical utility of the CRP in guiding antibiotic use in exacerbations of CF is limited.",
keywords = "antibiotic, C-reactive protein, exacerbation, pneumonia",
author = "Gayan Kathriachchige and Christopher Daley and Michael Pallin and Kevan Polkinghorne and King, {Paul T.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1111/imj.14106",
language = "English",
volume = "48",
pages = "1392--1395",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "11",

}

C-reactive protein levels in acute respiratory exacerbations of cystic fibrosis. / Kathriachchige, Gayan; Daley, Christopher; Pallin, Michael; Polkinghorne, Kevan; King, Paul T.

In: Internal Medicine Journal, Vol. 48, No. 11, 01.11.2018, p. 1392-1395.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - C-reactive protein levels in acute respiratory exacerbations of cystic fibrosis

AU - Kathriachchige, Gayan

AU - Daley, Christopher

AU - Pallin, Michael

AU - Polkinghorne, Kevan

AU - King, Paul T.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - C-reactive protein (CRP) levels increase in response to bacterial infection and have been used to guide the use of antibiotics. We assessed CRP levels in a cohort of patients with cystic fibrosis (CF) admitted to hospital with an exacerbation of their lung disease, requiring treatment with broad-spectrum antibiotics. In this group, most subjects had CRP levels of less than 20 mg/L, including patients who had pneumonia. The clinical utility of the CRP in guiding antibiotic use in exacerbations of CF is limited.

AB - C-reactive protein (CRP) levels increase in response to bacterial infection and have been used to guide the use of antibiotics. We assessed CRP levels in a cohort of patients with cystic fibrosis (CF) admitted to hospital with an exacerbation of their lung disease, requiring treatment with broad-spectrum antibiotics. In this group, most subjects had CRP levels of less than 20 mg/L, including patients who had pneumonia. The clinical utility of the CRP in guiding antibiotic use in exacerbations of CF is limited.

KW - antibiotic

KW - C-reactive protein

KW - exacerbation

KW - pneumonia

UR - http://www.scopus.com/inward/record.url?scp=85055882729&partnerID=8YFLogxK

U2 - 10.1111/imj.14106

DO - 10.1111/imj.14106

M3 - Article

VL - 48

SP - 1392

EP - 1395

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 11

ER -